Agamree

Active Ingredient(s): Vamorolone
FDA Approved: * October 26, 2023
Pharm Company: * SANTHERA PHARMA
Category: Genetic Disorders
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Agamree 40 mg/ml Oral Suspension
NDC: 62450-003
Labeler:
Purna Pharmaceuticals Nv
AgamreeAgamree Oral Kit
NDC: 69616-264
Labeler:
Catalyst Pharmaceuticals, Inc.